Two-day induction with thymoglobulin in kidney transplantation: Risks and benefits

Transplantation Proceedings

Volumn 36, Issue 1, 2004, Pages 76-79

  Uslu, A ^a,b   Nart, A ^a   Coker I ^a   Kose S ^a   Aykas, A ^a   Kahya, M C ^a   Yuzbasioglu M F ^a   Dogan M ^a  

^a SSK Izmir Hospital   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD19 ANTIGEN; CD3 ANTIGEN; CYCLOSPORIN A; GANCICLOVIR; METHYLPREDNISOLONE; PREDNISOLONE; THYMOCYTE ANTIBODY;

B LYMPHOCYTE; BRAIN ABSCESS; CADAVER; CONFERENCE PAPER; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DEATH; FLOW CYTOMETRY; FOLLOW UP; GRAFT REJECTION; HOSPITALIZATION; HUMAN; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RECIPIENT; REDUCTION; RHODOCOCCUS; RISK FACTOR; SEPTICEMIA; SURVIVAL RATE; T LYMPHOCYTE;

EID: 0842281689     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2003.11.042     Document Type: Conference Paper

References (17)

1. Matas A.J., Ramcharan T., Paraskevas S., et al. Rapid discontinuation of steroids in-living donor kidney transplantation a pilot study . Am J Transplantation. 1:2001;278.
2. Bourdage J.S., Hamlin D.M. Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry. Transplantation. 59:1995;1194.
3. Preville X., Flacher M., LeMauff B., et al. Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model. Transplantation. 71:2001;460.
4. Peters T.G., Shaver T.R., Ames J.E. 4th, et al. Cold ischemia and outcome in 17,937 cadaveric kidney transplants. Transplantation. 59:1995;191.
5. Calne R.Y. Prope tolerance a step in the search for tolerance in the clinic . World J Surg. 24:2000;793.
6. Almond P.S., Matas A., Gillingham K., et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation. 55:1993;752.
7. Agha I.A., Rueda J., Alvarez A., et al. Short course induction immunosuppression with thymoglobulin for renal transplant recipients. Transplantation. 73:2002;473.
8. Birkeland S.A. Steroid-free immunosuppression in renal transplantation a long-term follow-up of 100 consecutive patients . Transplantation. 71:2001;1089.
9. Djamali A., Turc-Baron C., Portales P., et al. Low dose antithymocyte globulins in renal transplantation daily versus intermittent administration based on T-cell monitoring . Transplantation. 69:2000;799.
10. Charpentier B. An induction versus no-induction protocol in anticalcineurin-based immunosuppression using very low-dose steroids. Transplant Proc. 33:2001;3S.
11. Lebranchu Y., Aubert P., Bayle F., et al. Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group. Transplant Proc. 32:2000;396.
12. Goggins WC, Pascual MA, Farrell ML, et al: Intraoperative versus postoperative administration of thymoglobulin in cadaveric renal transplantation. Abstract No: 0011. XIX International Congress of the Transplantation Society, 2002.
13. Abouna G.M., al-Abdullah I.H., Kelly-Sullivan D., et al. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring. Transplantation. 59:1995;1564.
14. Cosimi A.B., Wortis H.H., Delmonico F.L., et al. Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients importance of T cell monitoring . Surgery. 80:1976;155.
15. Brinchmann J.E., Vartdal F., Forset K.L., et al. A comparison of serial E-RFC monitoring and immunomagnetic quantitation of CD2+ cells in RATG-treated transplant recipients. Transplantation. 45:1988;804.
16. Brun P., Sterkers G., Maisin A., et al. Flow-cytometry monitoring of antilymphocyte globulin therapy in pediatric renal transplantation. Transplant Proc. 27:1995;1744.
17. Bock H.A., Gallati H., Zurcher R.M., et al. A randomized prospective trial of prophylactic immunosuppression with ATG-fresenius versus OKT3 after renal transplantation. Transplantation. 59:1995;830.